skip to main content
Show Results with:

Results 1 - 10 of 14  for Everything in this catalogue

results 1 2 next page
Refined by: publisher: Elsevier Science remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Misunderstandings, mandatory biopsies, and conflicts of interests in clinical trials: a coercive cocktail?

McNeil, Catriona M; Tattersall, Martin H N

The Lancet oncology. Volume 18:Issue 7 (2017); pp 851-852 -- Elsevier Science

Online access

2
Material Type:
Article
Add to My workspace

Misunderstandings, mandatory biopsies, and conflicts of interests in clinical trials: a coercive cocktail?

McNeil, Catriona M; Tattersall, Martin H N

The Lancet oncology. Volume 18:Issue 7 (2017); pp 851-852 -- Elsevier Science

Online access

3
Material Type:
Article
Add to My workspace

Bereaved and aggrieved in the age of social media

McNeil, Catriona M; Tattersall, Martin H N

The Lancet oncology. Volume 18:Issue 8 (2017); pp 1008- -- Elsevier Science

Online access

4
Material Type:
Article
Add to My workspace

Our Faustian pact with the digital world

McNeil, Catriona M; Harnett, Paul R

The Lancet oncology. Volume 18:Issue 2 (2017); pp 171-172 -- Elsevier Science

Online access

5
Material Type:
Article
Add to My workspace

Our Faustian pact with the digital world

McNeil, Catriona M; Harnett, Paul R

The Lancet oncology. Volume 18:Issue 2 (2017); pp 171-172 -- Elsevier Science

Online access

6
Material Type:
Article
Add to My workspace

Bereaved and aggrieved in the age of social media

McNeil, Catriona M; Tattersall, Martin H N

The Lancet oncology. Volume 18:Issue 8 (2017); pp 1008- -- Elsevier Science

Online access

7
Material Type:
Article
Add to My workspace

AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease

Nikolaou, Nikolaos et al.

Metabolism. Volume 99: (2019, October); pp 67-80 -- Elsevier Science

Online access

8
Material Type:
Article
Add to My workspace

Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial

Long, Georgina V et al.

The Lancet oncology. Volume 18:Issue 9 (2017); pp 1202-1210 -- Elsevier Science

Online access

9
Material Type:
Article
Add to My workspace

Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial

Judson, Ian et al.

The Lancet oncology. Volume 20:Number 7 (2019, July); pp 1023-1034 -- Elsevier Science

Online access

10
Material Type:
Article
Add to My workspace

Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial

Long, Georgina V et al.

The Lancet oncology. Volume 18:Issue 9 (2017); pp 1202-1210 -- Elsevier Science

Online access

Results 1 - 10 of 14  for Everything in this catalogue

results 1 2 next page

Refine Search Results

Searching Remote Databases, Please Wait